nodes	percent_of_prediction	percent_of_DWPC	metapath
Xylometazoline—ADRA1D—Signaling Pathways—PIK3CD—pancreatic cancer	0.000116	0.000116	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—PIK3CB—pancreatic cancer	0.000116	0.000116	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—TERT—pancreatic cancer	0.000116	0.000116	CbGpPWpGaD
Xylometazoline—ADRA2A—Hemostasis—HRAS—pancreatic cancer	0.000116	0.000116	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—NFKBIA—pancreatic cancer	0.000115	0.000115	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.000115	0.000115	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—NOTCH1—pancreatic cancer	0.000114	0.000114	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—KRAS—pancreatic cancer	0.000114	0.000114	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—CXCL8—pancreatic cancer	0.000114	0.000114	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—NFKBIA—pancreatic cancer	0.000114	0.000114	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—HRAS—pancreatic cancer	0.000113	0.000113	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—CXCL8—pancreatic cancer	0.000113	0.000113	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—NOTCH1—pancreatic cancer	0.000112	0.000112	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—PIK3CG—pancreatic cancer	0.000112	0.000112	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—NRAS—pancreatic cancer	0.000112	0.000112	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—CXCL8—pancreatic cancer	0.000112	0.000112	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—HRAS—pancreatic cancer	0.000111	0.000111	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—HIF1A—pancreatic cancer	0.000111	0.000111	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—TSC2—pancreatic cancer	0.000111	0.000111	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—EGF—pancreatic cancer	0.00011	0.00011	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR downstream signaling—AKT1—pancreatic cancer	0.00011	0.00011	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—PIK3CG—pancreatic cancer	0.00011	0.00011	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—NRAS—pancreatic cancer	0.00011	0.00011	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—CASP3—pancreatic cancer	0.000109	0.000109	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—EGFR—pancreatic cancer	0.000109	0.000109	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—EGF—pancreatic cancer	0.000109	0.000109	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—PIK3CG—pancreatic cancer	0.000109	0.000109	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—APOE—pancreatic cancer	0.000108	0.000108	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR downstream signaling—AKT1—pancreatic cancer	0.000108	0.000108	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—TERT—pancreatic cancer	0.000108	0.000108	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—CASP3—pancreatic cancer	0.000107	0.000107	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—CCND1—pancreatic cancer	0.000106	0.000106	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—KDR—pancreatic cancer	0.000106	0.000106	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—CTNNB1—pancreatic cancer	0.000105	0.000105	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—PIK3CD—pancreatic cancer	0.000105	0.000105	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—PIK3CA—pancreatic cancer	0.000105	0.000105	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—PPARG—pancreatic cancer	0.000105	0.000105	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—PIK3CA—pancreatic cancer	0.000104	0.000104	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—CCND1—pancreatic cancer	0.000104	0.000104	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—MMP9—pancreatic cancer	0.000103	0.000103	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—HIF1A—pancreatic cancer	0.000103	0.000103	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—CTNNB1—pancreatic cancer	0.000103	0.000103	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—KRAS—pancreatic cancer	0.000103	0.000103	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—TSC2—pancreatic cancer	0.000103	0.000103	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—PTEN—pancreatic cancer	0.000102	0.000102	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—PIK3CB—pancreatic cancer	0.000102	0.000102	CbGpPWpGaD
Xylometazoline—ADRA2A—Hemostasis—AKT1—pancreatic cancer	0.000102	0.000102	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—EGFR—pancreatic cancer	0.000102	0.000102	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—PIK3CB—pancreatic cancer	0.000101	0.000101	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—PTGS2—pancreatic cancer	0.000101	0.000101	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—MMP9—pancreatic cancer	0.000101	0.000101	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—NFKBIA—pancreatic cancer	0.000101	0.000101	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—APOE—pancreatic cancer	0.000101	0.000101	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—PTEN—pancreatic cancer	0.0001	0.0001	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—EGFR—pancreatic cancer	0.0001	0.0001	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—AKT1—pancreatic cancer	0.0001	0.0001	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—NOTCH1—pancreatic cancer	9.99e-05	9.99e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—KDR—pancreatic cancer	9.85e-05	9.85e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—PIK3CD—pancreatic cancer	9.82e-05	9.82e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—AKT1—pancreatic cancer	9.79e-05	9.79e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—PIK3CG—pancreatic cancer	9.76e-05	9.76e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—NRAS—pancreatic cancer	9.76e-05	9.76e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—CXCL8—pancreatic cancer	9.75e-05	9.75e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—PIK3CA—pancreatic cancer	9.73e-05	9.73e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—HRAS—pancreatic cancer	9.69e-05	9.69e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—PIK3CD—pancreatic cancer	9.66e-05	9.66e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—EGF—pancreatic cancer	9.65e-05	9.65e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—KRAS—pancreatic cancer	9.61e-05	9.61e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—PIK3CA—pancreatic cancer	9.57e-05	9.57e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—PIK3CD—pancreatic cancer	9.54e-05	9.54e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—SRC—pancreatic cancer	9.5e-05	9.5e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—KRAS—pancreatic cancer	9.46e-05	9.46e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—PIK3CA—pancreatic cancer	9.46e-05	9.46e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—AKT1—pancreatic cancer	9.42e-05	9.42e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—NFKBIA—pancreatic cancer	9.37e-05	9.37e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—CASP3—pancreatic cancer	9.33e-05	9.33e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—SRC—pancreatic cancer	9.3e-05	9.3e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—NOTCH1—pancreatic cancer	9.28e-05	9.28e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—VEGFA—pancreatic cancer	9.26e-05	9.26e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—STAT3—pancreatic cancer	9.16e-05	9.16e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—PIK3CB—pancreatic cancer	9.16e-05	9.16e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—NRAS—pancreatic cancer	9.14e-05	9.14e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—CCND1—pancreatic cancer	9.09e-05	9.09e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—PIK3CG—pancreatic cancer	9.07e-05	9.07e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—NRAS—pancreatic cancer	9.07e-05	9.07e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—VEGFA—pancreatic cancer	9.06e-05	9.06e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—CTNNB1—pancreatic cancer	9e-05	9e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—STAT3—pancreatic cancer	8.97e-05	8.97e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—EGF—pancreatic cancer	8.97e-05	8.97e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—NRAS—pancreatic cancer	8.95e-05	8.95e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—EGFR—pancreatic cancer	8.9e-05	8.9e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—PTEN—pancreatic cancer	8.85e-05	8.85e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—PIK3CA—pancreatic cancer	8.83e-05	8.83e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—MMP9—pancreatic cancer	8.82e-05	8.82e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—CXCL8—pancreatic cancer	8.81e-05	8.81e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—PTEN—pancreatic cancer	8.77e-05	8.77e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—HRAS—pancreatic cancer	8.75e-05	8.75e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—PIK3CA—pancreatic cancer	8.69e-05	8.69e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—PIK3CD—pancreatic cancer	8.58e-05	8.58e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—PIK3CB—pancreatic cancer	8.56e-05	8.56e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—AKT1—pancreatic cancer	8.56e-05	8.56e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—MYC—pancreatic cancer	8.52e-05	8.52e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—AKT1—pancreatic cancer	8.51e-05	8.51e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—PIK3CA—pancreatic cancer	8.5e-05	8.5e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—TGFB1—pancreatic cancer	8.5e-05	8.5e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—CASP3—pancreatic cancer	8.43e-05	8.43e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—PIK3CB—pancreatic cancer	8.42e-05	8.42e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—KRAS—pancreatic cancer	8.4e-05	8.4e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—MYC—pancreatic cancer	8.34e-05	8.34e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—EGFR—pancreatic cancer	8.33e-05	8.33e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—TGFB1—pancreatic cancer	8.32e-05	8.32e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—PIK3CB—pancreatic cancer	8.31e-05	8.31e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—EGFR—pancreatic cancer	8.27e-05	8.27e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—PTGS2—pancreatic cancer	8.24e-05	8.24e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CXCL8—pancreatic cancer	8.23e-05	8.23e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—CCND1—pancreatic cancer	8.2e-05	8.2e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—HRAS—pancreatic cancer	8.17e-05	8.17e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—EGFR—pancreatic cancer	8.16e-05	8.16e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—SRC—pancreatic cancer	8.13e-05	8.13e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—CTNNB1—pancreatic cancer	8.12e-05	8.12e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CXCL8—pancreatic cancer	8.09e-05	8.09e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—HRAS—pancreatic cancer	8.04e-05	8.04e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—PIK3CD—pancreatic cancer	7.98e-05	7.98e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—MMP9—pancreatic cancer	7.96e-05	7.96e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—AKT1—pancreatic cancer	7.95e-05	7.95e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—VEGFA—pancreatic cancer	7.92e-05	7.92e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—PTEN—pancreatic cancer	7.92e-05	7.92e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—PIK3CA—pancreatic cancer	7.9e-05	7.9e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CASP3—pancreatic cancer	7.87e-05	7.87e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—KRAS—pancreatic cancer	7.87e-05	7.87e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—STAT3—pancreatic cancer	7.84e-05	7.84e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—NRAS—pancreatic cancer	7.82e-05	7.82e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—AKT1—pancreatic cancer	7.82e-05	7.82e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—KRAS—pancreatic cancer	7.81e-05	7.81e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CASP3—pancreatic cancer	7.75e-05	7.75e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—AKT1—pancreatic cancer	7.72e-05	7.72e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—PIK3CA—pancreatic cancer	7.72e-05	7.72e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—KRAS—pancreatic cancer	7.7e-05	7.7e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CCND1—pancreatic cancer	7.66e-05	7.66e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CTNNB1—pancreatic cancer	7.59e-05	7.59e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CCND1—pancreatic cancer	7.54e-05	7.54e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—PIK3CB—pancreatic cancer	7.48e-05	7.48e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CTNNB1—pancreatic cancer	7.47e-05	7.47e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—MMP9—pancreatic cancer	7.44e-05	7.44e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—PTEN—pancreatic cancer	7.4e-05	7.4e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—SRC—pancreatic cancer	7.34e-05	7.34e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—MMP9—pancreatic cancer	7.32e-05	7.32e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—MYC—pancreatic cancer	7.29e-05	7.29e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—PTEN—pancreatic cancer	7.28e-05	7.28e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—TGFB1—pancreatic cancer	7.27e-05	7.27e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—PIK3CA—pancreatic cancer	7.23e-05	7.23e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—AKT1—pancreatic cancer	7.22e-05	7.22e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CXCL8—pancreatic cancer	7.19e-05	7.19e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—PTEN—pancreatic cancer	7.18e-05	7.18e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—PIK3CA—pancreatic cancer	7.17e-05	7.17e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—VEGFA—pancreatic cancer	7.15e-05	7.15e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—HRAS—pancreatic cancer	7.14e-05	7.14e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—EGFR—pancreatic cancer	7.13e-05	7.13e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—AKT1—pancreatic cancer	7.1e-05	7.1e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—STAT3—pancreatic cancer	7.08e-05	7.08e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—PIK3CA—pancreatic cancer	7.08e-05	7.08e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—NRAS—pancreatic cancer	7.06e-05	7.06e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—TP53—pancreatic cancer	6.99e-05	6.99e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—PIK3CB—pancreatic cancer	6.95e-05	6.95e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—AKT1—pancreatic cancer	6.95e-05	6.95e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CASP3—pancreatic cancer	6.88e-05	6.88e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—SRC—pancreatic cancer	6.86e-05	6.86e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—TP53—pancreatic cancer	6.85e-05	6.85e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—SRC—pancreatic cancer	6.75e-05	6.75e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—KRAS—pancreatic cancer	6.73e-05	6.73e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CCND1—pancreatic cancer	6.7e-05	6.7e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—HRAS—pancreatic cancer	6.69e-05	6.69e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CXCL8—pancreatic cancer	6.68e-05	6.68e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—VEGFA—pancreatic cancer	6.68e-05	6.68e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—HRAS—pancreatic cancer	6.64e-05	6.64e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CTNNB1—pancreatic cancer	6.63e-05	6.63e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—STAT3—pancreatic cancer	6.61e-05	6.61e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—NRAS—pancreatic cancer	6.6e-05	6.6e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—MYC—pancreatic cancer	6.58e-05	6.58e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—VEGFA—pancreatic cancer	6.57e-05	6.57e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—TGFB1—pancreatic cancer	6.56e-05	6.56e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—HRAS—pancreatic cancer	6.55e-05	6.55e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—STAT3—pancreatic cancer	6.51e-05	6.51e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—MMP9—pancreatic cancer	6.5e-05	6.5e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—NRAS—pancreatic cancer	6.49e-05	6.49e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—PTEN—pancreatic cancer	6.47e-05	6.47e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—AKT1—pancreatic cancer	6.45e-05	6.45e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—EGFR—pancreatic cancer	6.44e-05	6.44e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CASP3—pancreatic cancer	6.39e-05	6.39e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—AKT1—pancreatic cancer	6.31e-05	6.31e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—PIK3CA—pancreatic cancer	6.24e-05	6.24e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CCND1—pancreatic cancer	6.22e-05	6.22e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—PIK3CA—pancreatic cancer	6.19e-05	6.19e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CTNNB1—pancreatic cancer	6.16e-05	6.16e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—MYC—pancreatic cancer	6.15e-05	6.15e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—TGFB1—pancreatic cancer	6.13e-05	6.13e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—KRAS—pancreatic cancer	6.08e-05	6.08e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—MYC—pancreatic cancer	6.05e-05	6.05e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—MMP9—pancreatic cancer	6.04e-05	6.04e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—TGFB1—pancreatic cancer	6.03e-05	6.03e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—EGFR—pancreatic cancer	6.01e-05	6.01e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—PTEN—pancreatic cancer	6.01e-05	6.01e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—SRC—pancreatic cancer	6e-05	6e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—TP53—pancreatic cancer	5.99e-05	5.99e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—EGFR—pancreatic cancer	5.92e-05	5.92e-05	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—AKT1—pancreatic cancer	5.91e-05	5.91e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—AKT1—pancreatic cancer	5.86e-05	5.86e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—VEGFA—pancreatic cancer	5.84e-05	5.84e-05	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—AKT1—pancreatic cancer	5.78e-05	5.78e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—STAT3—pancreatic cancer	5.78e-05	5.78e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—NRAS—pancreatic cancer	5.77e-05	5.77e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—HRAS—pancreatic cancer	5.72e-05	5.72e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—KRAS—pancreatic cancer	5.68e-05	5.68e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—KRAS—pancreatic cancer	5.59e-05	5.59e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—PIK3CA—pancreatic cancer	5.59e-05	5.59e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—SRC—pancreatic cancer	5.57e-05	5.57e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—VEGFA—pancreatic cancer	5.43e-05	5.43e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—TP53—pancreatic cancer	5.4e-05	5.4e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—MYC—pancreatic cancer	5.37e-05	5.37e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—STAT3—pancreatic cancer	5.37e-05	5.37e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—TGFB1—pancreatic cancer	5.36e-05	5.36e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—NRAS—pancreatic cancer	5.36e-05	5.36e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—EGFR—pancreatic cancer	5.26e-05	5.26e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—PIK3CA—pancreatic cancer	5.22e-05	5.22e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—HRAS—pancreatic cancer	5.17e-05	5.17e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—PIK3CA—pancreatic cancer	5.14e-05	5.14e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—AKT1—pancreatic cancer	5.1e-05	5.1e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—PIK3CA—pancreatic cancer	5.07e-05	5.07e-05	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—AKT1—pancreatic cancer	5.05e-05	5.05e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—TP53—pancreatic cancer	5.05e-05	5.05e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—MYC—pancreatic cancer	4.99e-05	4.99e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—TGFB1—pancreatic cancer	4.98e-05	4.98e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—TP53—pancreatic cancer	4.97e-05	4.97e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—KRAS—pancreatic cancer	4.96e-05	4.96e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—EGFR—pancreatic cancer	4.88e-05	4.88e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—HRAS—pancreatic cancer	4.83e-05	4.83e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—HRAS—pancreatic cancer	4.75e-05	4.75e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—KRAS—pancreatic cancer	4.61e-05	4.61e-05	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—AKT1—pancreatic cancer	4.56e-05	4.56e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—PIK3CA—pancreatic cancer	4.56e-05	4.56e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—TP53—pancreatic cancer	4.41e-05	4.41e-05	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—AKT1—pancreatic cancer	4.26e-05	4.26e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—PIK3CA—pancreatic cancer	4.24e-05	4.24e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—HRAS—pancreatic cancer	4.22e-05	4.22e-05	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—AKT1—pancreatic cancer	4.19e-05	4.19e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—AKT1—pancreatic cancer	4.14e-05	4.14e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—TP53—pancreatic cancer	4.1e-05	4.1e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—HRAS—pancreatic cancer	3.92e-05	3.92e-05	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—AKT1—pancreatic cancer	3.73e-05	3.73e-05	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—AKT1—pancreatic cancer	3.46e-05	3.46e-05	CbGpPWpGaD
